PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
The Liver Cancer Time Burden: What Patients and Caregivers Need to Know. Liver cancer treatment often involves months to years of therapy, monitoring, and recovery. Learn the real-time burden of hepatocellular
Continue readingFenbendazole and Liver Cancer: What the Research Really Shows. In recent years, fenbendazole (often shortened to “fenben”) has gained attention online as a possible alternative cancer therapy. Stories
Continue readingLiver Cancer – Need To Know- A diagnosis of liver cancer can be overwhelming. Liver cancer — most commonly hepatocellular carcinoma (HCC)— is a serious disease that arises when abnormal cells in
Continue readingSorafenib is a multikinase inhibitor used for the treatment of uHCC 10 Two Phase III studies (SHARP and Asia-Pacific) demonstrated significant improvements in overall survival in Hepatocellular Carcinoma
Continue readingOur results provide firm evidence for the efficacy of the applied regimen, with close to 80% of pediatric liver cancer patients achieving complete remission at the end of treatment. The study linked
Continue reading